Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Interferon alfa is an immunomodulator used to treat hepatitis B and C as well as certain types of cancer including cutaneous T-cell lymphoma and renal cell carcinoma. Natural interferon alpha or Multiferon is obtained from the leukocyte fraction of human blood following induction with Sendai virus.
- Mechanism
- Curator reviewed
Natural alpha interferon offers multiple subtypes of interferon which may work together as a 'cocktail-in-one', while recombinant versions only exhibit a single subtype." Viragen offers MultiferonT at a cost which is competitive with recombinant interferon regimens.
Natural alpha interferon contains the multiple subtype composition that is characteristic of interferon produced by the human body. It is believed that this results in a broader spectrum of specific anti-viral and immunoregulatory activity with the subtypes acting synergistically to give a wide-ranging response.
- Primary indication
- Investigated for use/treatment in hepatitis (viral, C), leukemia (lymphoid), leukemia (myeloid), leukemia (unspecified), and melanoma.Curator reviewed · 6 structured indications
- Formula / weight
- 20700.0 Da (range 19300-22100)
- Also known as
- alfa interferon · HuIFN-alpha-Le · IFN-α · Natural alpha interferon
Resolves to
What you can answer from here — as of April 16, 2026
Which drugs share a target with Interferon alfa, and which of those have an active Phase 3 trial?